Fed. Circ. Won't Touch Hypertension Drug Patent Ruling

The Federal Circuit decided Wednesday to leave untouched a ruling from the patent board that found there was nothing patentable about a purportedly new way of administering a blockbuster pulmonary hypertension...

Already a subscriber? Click here to view full article